UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

Impact of beta blockers on epithelial ovarian cancer survival

Gynecologic oncology, 2012-11, Vol.127 (2), p.375-378

2012

Link zum Volltext

Verfügbarkeit prüfen

Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction

Gynecologic oncology, 2017-12, Vol.147 (3), p.705-713

2017

Link zum Volltext

Verfügbarkeit prüfen

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers

Gynecologic oncology, 2016-11, Vol.143 (2), p.231-235

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer

Gynecologic oncology, 2017-07, Vol.146 (1), p.146-152

2017

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of 10-year survivors of high-grade serous ovarian carcinoma

Gynecologic oncology, 2016-05, Vol.141 (2), p.260-263

2016

Link zum Volltext

Verfügbarkeit prüfen

Gynecologic Oncology : An update on our progress

Gynecologic oncology, 2014-03, Vol.132 (3), p.515-516

2014

Link zum Volltext

Verfügbarkeit prüfen

Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition

Gynecologic oncology, 2010-01, Vol.116 (1), p.117-125

2010

Link zum Volltext

Verfügbarkeit prüfen

Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach

Gynecologic oncology, 2017-07, Vol.146 (1), p.101-108

2017

Link zum Volltext

Verfügbarkeit prüfen

Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells

Gynecologic oncology, 2010-12, Vol.119 (3), p.549-556

2010

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 promoter methylation predicts adverse ovarian cancer prognosis

Gynecologic oncology, 2006-06, Vol.101 (3), p.403-410

2006

Link zum Volltext

Verfügbarkeit prüfen

Impact of statin therapy on survival in epithelial ovarian cancer

Gynecologic oncology, 2008-10, Vol.111 (1), p.102-105

2008

Link zum Volltext

Verfügbarkeit prüfen

Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening

Gynecologic oncology, 2010-03, Vol.116 (3), p.516-521

2010

Link zum Volltext

Verfügbarkeit prüfen

Can molecular subtyping be used to triage women with advanced ovarian cancer to Primary Debulking Surgery or Neoadjuvant Chemotherapy?

Gynecologic oncology, 2019-02, Vol.152 (2), p.221-222

2019

Link zum Volltext

Verfügbarkeit prüfen

Gynecologic Oncology 2017 Update: New Features and Expanded Scope

Gynecologic oncology, 2017-01, Vol.144 (1), p.1-2

Karlan, Beth Y

2017

Link zum Volltext

Verfügbarkeit prüfen

Stathmin 1 and p16INK4A are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma

Gynecologic oncology, 2015-10, Vol.139 (1), p.104-111

2015

Link zum Volltext

Verfügbarkeit prüfen

Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model

Gynecologic oncology, 2020-10, Vol.159 (1), p.277-284

2020

Link zum Volltext

Verfügbarkeit prüfen

Sexual harassment in the work place: Its impact on gynecologic oncology and women's health

Gynecologic oncology, 2018-05, Vol.149 (2), p.227-229

2018

Link zum Volltext

Verfügbarkeit prüfen

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk

Gynecologic oncology, 2007-03, Vol.104 (3), p.660-664

2007

Link zum Volltext

Verfügbarkeit prüfen

Dawn of a New Cover

Gynecologic oncology, 2015-04, Vol.137 (1), p.1-1

Karlan, Beth Y

2015

Link zum Volltext

Verfügbarkeit prüfen

Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation

Gynecologic oncology, 2015-12, Vol.139 (3), p.394-400

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers

Gynecologic oncology, 2010-01, Vol.116 (1), p.105-108

2010

Link zum Volltext

Verfügbarkeit prüfen

The CROWN Initiative: Journal editors invite researchers to develop core outcomes in women's health

Gynecologic oncology, 2014-09, Vol.134 (3), p.443-444

Karlan, Beth Y

2014

Link zum Volltext

Verfügbarkeit prüfen

PARP inhibitor maintenance for primary ovarian cancer – A missed opportunity for precision medicine

Gynecologic oncology, 2021-10, Vol.163 (1), p.11-13

2021

Link zum Volltext

Verfügbarkeit prüfen

Recurrence and risk of progression to lower genital tract malignancy in women with high grade VAIN

Gynecologic oncology, 2016-06, Vol.141 (3), p.507-510

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictors of survival trajectories among women with epithelial ovarian cancer

Gynecologic oncology, 2020-02, Vol.156 (2), p.459-466

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 95

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieGynecologic Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(95)

Sprache

Englisch
(95)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Oncology
(87)
Life Sciences & Biomedicine
(85)
Obstetrics & Gynecology
(85)
Science & Technology
(85)
Humans
(82)
Female
(80)
Obstetrics And Gynecology
(57)
Hematology, Oncology And Palliative Medicine
(51)
Middle Aged
(42)
Ovarian Neoplasms - Pathology
(36)
Ovarian Cancer
(35)
Aged
(33)
Adult
(29)
Ovarian Neoplasms - Genetics
(24)
Aged, 80 And Over
(23)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Ovarian Neoplasms - Drug Therapy
(18)
Neoplasm Staging
(16)
Ovarian Neoplasms - Surgery
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(95)
Ingenta
(95)
Elsevier ScienceDirect Journals Complete
(95)
MEDLINE
(82)
IngentaConnect Journals
(55)

Zeitschrift / Serie

Gynecol Oncol
(2)

Menü

Weitere Dienste

Einstellungen

Impact of beta blockers on epithelial ovarian cancer survival

Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers

Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer

Characteristics of 10-year survivors of high-grade serous ovarian carcinoma

Gynecologic Oncology : An update on our progress

Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition

Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach

Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells

BRCA1 promoter methylation predicts adverse ovarian cancer prognosis

Impact of statin therapy on survival in epithelial ovarian cancer

Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening

Can molecular subtyping be used to triage women with advanced ovarian cancer to Primary Debulking Surgery or Neoadjuvant Chemotherapy?

Gynecologic Oncology 2017 Update: New Features and Expanded Scope

Stathmin 1 and p16INK4A are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma

Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model

Sexual harassment in the work place: Its impact on gynecologic oncology and women's health

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk

Dawn of a New Cover

Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation

Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers

The CROWN Initiative: Journal editors invite researchers to develop core outcomes in women's health

PARP inhibitor maintenance for primary ovarian cancer – A missed opportunity for precision medicine

Recurrence and risk of progression to lower genital tract malignancy in women with high grade VAIN

Predictors of survival trajectories among women with epithelial ovarian cancer

Aktive Filter

Suchergebnisse filtern